These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7057400)

  • 1. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP; Casu B; Torri G
    Arzneimittelforschung; 1985; 35(8):1215-9. PubMed ID: 4074437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
    Shimotori T; Sakuragawa N
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro release of lipoprotein lipase and hepatic lipase by low molecular weight heparins.
    Meraihi Z; Lutz O; Frey A; Bach AC
    Arch Int Pharmacodyn Ther; 1989; 297():286-93. PubMed ID: 2543347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention of antilipemic activity by periodate-oxidized non-anticoagulant heparins.
    Casu B; Diamantini G; Fedeli G; Mantovani M; Oreste P; Pescador R; Porta R; Prino G; Torri G; Zoppetti G
    Arzneimittelforschung; 1986 Apr; 36(4):637-42. PubMed ID: 3013215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
    Cesaretti M; Luppi E; Maccari F; Volpi N
    Glycobiology; 2004 Dec; 14(12):1275-84. PubMed ID: 15253929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of high affinity heparin fractions and their anticoagulant and lipase activity.
    de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Verschoor L; Bouma BN; Sixma JJ
    Blood; 1984 Apr; 63(4):836-42. PubMed ID: 6704544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activity.
    Palm M; Mattsson C; Svahn CM; Weber M
    Thromb Haemost; 1990 Aug; 64(1):127-32. PubMed ID: 2177229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes.
    Bianchini P; Liverani L; Mascellani G; Parma B
    Semin Thromb Hemost; 1997; 23(1):3-10. PubMed ID: 9156404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(10):1621-3. PubMed ID: 7192096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticoagulant, hepatic lipase-releasing and lipoprotein lipase-releasing activities of several natural and chemically modified heparins differ.
    Pescador R; Porta R; Niada R; Diamantini G; Fedeli G; Mantovani M
    Biochem Pharmacol; 1987 Jan; 36(2):253-7. PubMed ID: 3814169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic characterization of a medium-molecular-weight heparin in comparison with UFH and LMWH.
    Alban S; Welzel D; Hemker HC
    Semin Thromb Hemost; 2002 Aug; 28(4):369-78. PubMed ID: 12244484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved method for removal of antithrombin III from post-heparin plasma lipase fractions with a high recovery rate.
    Moriguchi EH; Tamachi H; Homma Y; Goto Y
    Tokai J Exp Clin Med; 1991 Mar; 16(1):33-41. PubMed ID: 1780907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of lipoprotein lipase and hepatic lipase activities. Effects of heparin and a low molecular weight heparin fragment.
    Persson E; Nilsson-Ehle P
    Scand J Clin Lab Invest; 1990 Feb; 50(1):43-9. PubMed ID: 2156335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.